XML 46 R34.htm IDEA: XBRL DOCUMENT v3.24.3
Fair Value of Financial Instruments (Tables)
3 Months Ended
Sep. 30, 2024
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value
The following table summarizes the valuation of the Company’s remaining assets and liabilities measured at fair value on a recurring basis at September 30, 2024:
TotalQuoted
prices in
active
markets
(Level 1)
Significant
other
observable
inputs
(Level 2)
Significant
unobservable
inputs
(Level 3)
 (in thousands)
Assets:
Deferred compensation plan investments, current and non-current$32,176 $32,176 $ $ 
Forward foreign currency exchange contracts17  17  
Interest rate swap agreement1,305  1,305  
Total assets at fair value$33,498 $32,176 $1,322 $ 
Liabilities:
Deferred compensation plan investments, current and non-current$32,176 $32,176 $ $ 
Foreign currency hedge53  53  
Liability for contingent consideration, current and non-current17,200   17,200 
Total liabilities at fair value$49,429 $32,176 $53 $17,200 

The following table summarizes the valuation of the Company’s remaining assets and liabilities measured at fair value on a recurring basis at June 30, 2024:
TotalQuoted
prices in
active
markets
(Level 1)
Significant
other
observable
inputs
(Level 2)
Significant
unobservable
inputs
(Level 3)
 (in thousands)
Assets:
Deferred compensation plan investments, current and non-current $31,014 $31,014 $— $— 
Foreign currency hedge345 — 345 — 
Interest rate swap agreement2,698 — 2,698 — 
Total assets at fair value$34,057 $31,014 $3,043 $— 
Liabilities:
Deferred compensation plan investments, current and non-current$31,014 $31,014 $— $— 
Forward foreign currency exchange contracts12 — 12 — 
Total liabilities at fair value$31,026 $31,014 $12 $— 
Schedule of Changes in Fair Value of Contingent Considerations
Valuation techniques and significant observable inputs used in recurring Level 3 fair value measurements for the Company's contingent consideration liabilities related to Advantix and Resourcive at September 30, 2024 were as follows.
AcquisitionReporting PeriodValuation TechniqueSignificant Unobservable InputsWeighted Average Rates
AdvantixSeptember 30, 2024Discounted cash flowAdjusted EBITDA risk premium15.7 %
Adjusted EBITDA growth rate19.8 %
ResourciveSeptember 30, 2024Monte CarloAdjusted EBITDA risk premium13.6 %
Simulated commission growth percentage23.7 %